AstraZeneca puts COVID-19 vaccination trial on hold
The drug company that’s testing a potential COVID-19 vaccine at two Chicago locations, among other places, has put its clinical trial on hold due to a potential severe adverse reaction for a participant at a different site.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
